Editorial Commentary
The prediction of response to immunotherapy in non-small cell lung cancer patients by 18F-FDG PET/CT
Abstract
The role of FDG PET/CT in patients scheduled or undergoing immunotherapy is still unclear, particularly in those affected by non-small cell lung cancer (NSCLC).
